Search results
MeridianLink, Inc. (NYSE:MLNK) Receives Consensus Recommendation of “Hold” from Analysts
ETF DAILY NEWS· 5 hours agoMeridianLink, Inc. (NYSE:MLNK – Get Free Report) has been assigned an average rating of “Hold” from...
Q1 2024 Mettler-Toledo International Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 23 minutes agoShawn P. Vadala; CFO; Mettler-Toledo International Inc. Catherine Walden Ramsey Schulte; Senior Research Analyst ; Robert W. Baird & Co. Incorporated, Research Division Daniel ...
Q1 2024 Humacyte Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoKristen Kluska; Analyst; Cantor Fitzgerald & Co. Bruce Jackson; Analyst; The Benchmark Company, LLC Josh Jennings...
Warner Bros. Discovery Eyes Turnaround with Upcoming Disney+ Bundle and NBA Deal, Analysts Say -...
Benzinga· 11 hours agoKeybanc analyst Brandon Nispel upgraded Warner Bros. Discovery Inc WBD from Sector Weight to...
Q1 2024 Soho House & Co Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 52 minutes ago...Soho House & Co Inc Andrew Carnie; President, Chief Executive Officer, Director; Soho House & Co Inc Shaun Kelley; Analyst; Bank of America George Kelly; Analyst; ROTH MKM Sharon Zackfia; Analyst; William Blair & Company Steven Zaccone; Analyst...
Broker Bets: The 3 Most Notable Analyst Upgrades to Know About Now
InvestorPlace· 9 hours agoFollowing analyst upgrades on Wall Street can provide investors valuable insights into the most...
11 Best Farmland and Agriculture Stocks To Buy According to Analysts
Insider Monkey via Yahoo Finance· 6 hours agoIn this article, we discuss the 11 best farmland and agriculture stocks to buy according to analysts...
Analysts reboot Palantir stock price target after earnings
TheStreet via Yahoo Finance· 3 days agoAlex Karp didn't hold back on Monday night "I think it is fair to say we crushed Q1 in the U.S.,"...
Research Analysts Issue Forecasts for X4 Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:XFOR)
ETF DAILY NEWS· 4 hours agoX4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Stock analysts at Brookline Capital Management dropped their Q2 2024 earnings per share estimates for shares of X4 Pharmaceuticals ...
Analyst Says Dogecoin(DOGE) Is a 'Crapshoot,' Could These 3 Meme Coins Have Higher Returns?
Benzinga via Yahoo Finance· 14 hours agoHowever, the token has seen some of the largest returns of any asset over the past decade. This feat...